Home | FAQs |
     The Plan   |   Additions and Updates   |   Monitoring and Reporting   |   Filling the Funding Gap   |   News and Events   |   Support the Plan
About the Funding Gaps

Funding Gaps by Region
Funding Gaps by Area of Activity

DOTS Expansion
DOTS-Plus for MDR-TB
TB/HIV
ACSM
New TB Diagnostics
New TB Drugs
New TB Vaccines
Call for Filling the Gaps

What We Do

What You Can Do


TB is a common opportunistic infection in people with HIV and a leading cause of death among people living with HIV/AIDS. As two diseases are so closely connected and they increase each other's impact, TB control is pivotal to HIV/AIDS treatment and care.

TB/HIV activities are not a substitute for well-functioning DOTS-based TB programmes and comprehensive HIV/AIDS prevention and care programmes. Instead they aim to build on existing programmes to deliver comprehensive, high-quality, accessible, patient-centred prevention, care and support services to people affected by TB and HIV - two diseases that often occur in the same community or the same patient.

The full implementation of the Global Plan's TB/HIV activities, including some aspects of technical cooperation, requires US$6.7 billion over ten years.

Budget requirements for the TB/HIV Working Group, 2006-2015 (US$ millions)
PDF format, Powerpoint format



"We cannot win the battle against AIDS if we do not also fight TB. TB is too often a death sentence for people with AIDS"

- Nelson Mandela


Fight AIDS Fight TB Fight Now


With effective treatment TB can be cured, HIV managed, and lives saved. Read more